Skip to Content
Merck
  • Exploring binding properties of agonists interacting with a δ-opioid receptor.

Exploring binding properties of agonists interacting with a δ-opioid receptor.

PloS one (2013-01-10)
Francesca Collu, Matteo Ceccarelli, Paolo Ruggerone
ABSTRACT

Ligand-receptor interactions are at the basis of the mediation of our physiological responses to a large variety of ligands, such as hormones, neurotransmitters and environmental stimulants, and their tuning represents the goal of a large variety of therapies. Several molecular details of these interactions are still largely unknown. In an effort to shed some light on this important issue, we performed a computational study on the interaction of two related compounds differing by a single methyl group (clozapine and desmethylclozapine) with a [Formula: see text]-opioid receptor. According to experiments, desmethylclozapine is more active than clozapine, providing a system well suited for a comparative study. We investigated stable configurations of the two drugs inside the receptor by simulating their escape routes by molecular dynamics simulations. Our results point out that the action of the compounds might be related to the spatial and temporal distribution of the affinity sites they visit during their permanency. Moreover, no particularly pronounced structural perturbations of the receptor were detected during the simulations, reinforcing the idea of a strong dynamical character of the interaction process, with an important role played by the solvent in addition.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
N-Desmethylclozapine
Supelco
N-Desmethylclozapine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®